(ANIP - ANI PHARMACEUTICALS INC)

company profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Ani Pharmaceuticals (ANIP) is trading at 81.86

Open Price
87.76
Previous close
81.86
Previous close
81.86
P/E Ratio
25.1621
Sector
Health Care
Shares outstanding
22761062
Index
R2000,R3000
Primary exchange
NASDAQ-NMS
ISIN
US00182C1036